MIR Acquisition Seals $7M in Series A Financing
Ann Arbor-based MIR Acquisition, which operates as Molecular Imaging Research Inc., has closed on $7 million in Series A venture financing. Baird Venture Partners and Arcus Ventures co-led the round, which is designed to help MIR expand and commercialize its technology. The company specializes in the in vivo preclinical imaging of small animals, technology used by pharmaceutical, biotechnology and medical devices companies.
9 May 2011•4 mins read
